Tag: 5 ht1a agonist

Approved by the FDA in 2023 after a multi-decade journey, gepirone (marketed as Exxua) offers a new treatment option for adults with major depressive disorder (MDD). Discover what class of medication is gepirone and how its novel mechanism of action sets it apart from more traditional antidepressants.

Gepirone, recently approved by the FDA for treating major depressive disorder (MDD) in adults, operates with a unique pharmacological approach compared to many other antidepressants. As a member of the azapirone class, **what is the mechanism of action of gepirone** involves the selective modulation of serotonergic activity in the brain, offering a novel treatment option for mood disorders.